podcast

Scrip M&A Podcast: Will the FDA Staff Cuts Affect Biopharma M&A Activity?

01.05.2025
Сүйікті платформалардағы эпизодты тыңдаңыз:
  • Apple Podcasts
  • Spotify
  • Castbox
  • Pocket Casts
  • iHeart
  • PlayerFM
  • Overcast
  • Castro
  • RadioPublic
Scrip senior writer Joseph Haas discusses the potential impact of the recent FDA staff cuts with attorneys Andrew Goodman of Paul Hastings LLP and Alan Minsk of Arnall Golden Gregory, as well as Naya Therapeutics CEO Daniel Teper
email
Auto light/dark, in dark modeAuto light/dark, in light modeDark modeLight mode

© 2020–2025 PC.ST

Подкастинг жайлы оқу — podcasts.ru

Сайт әзірлеуші — Pavel Kozlov

Дизайн — Bonkers!

Scrip M&A Podcast: Will the FDA Staff Cuts Affect Biopharma M&A Activity?
00:40:27